Skip to main content

Biologics/Biosimilars Webinar Series: Post-Market Legal and Regulatory Issues


Date: April 7, 2016

Time: 11:00AM - 12:00PM

Location: Webinar


  • Post-Market Legal and Regulatory Issues

Event Details

In the face of rising drug costs, patients, payors, and Congress have increasingly focused on the potential cost savings of biosimilars. But given that the first biosimilar hit the market less than a year ago, there are many unanswered questions surrounding the promise of biosimilars. In this fifth installment of our biologics/biosimilars series, we'll focus on the path forward for biosimilars within the pharmaceutical industry.


Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.